Stefano Buono

Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France.

European Organization for Nuclear Research engages in the research of physics. Its main area of research is particle physics which is the study of the fundamental constituents of matter and the forces acting between them. The company was founded in 1954 and is headquartered in Geneva, Switzerland.

Cerner France SAS specializes in information technology solutions for the healthcare industry. The firm offers financial, administrative, and clinical solutions. The company was founded in 1989 and is headquartered in Puteaux, France.

Planet Holding Ltd. invests in companies that provides smart solutions in the areas of built environment, technological systems, ecosystem resources, and society. The company was founded by Susanna Marchionni and Giovanni Savio and is headquartered in London, the United Kingdom.

Health Technology Holding Srl (HTC), is a venture capital subsidiary of Gefim SpA founded in 2019. The firm is headquartered in Milan, Italy.

Elysia Capital Ltd (Elysia Capital) is an independent venture capital firm founded in 206 by Stefano Buono and Maribel Lopera Sierra. The firm is headquartered in London.

LiftT SpA (LiftT) is a venture capital firm founded in 2019. The firm is headquartered in Turin, Italy.

Newcleo Ltd. is a British company that is disrupting the nuclear energy industry to play its part in climate change mitigation and decarbonization. Newcleo is based in an undisclosed location. The company is focused on reducing the environmental impact of nuclear fission and providing safe and clean energy to meet the growing energy needs. Newcleo has announced an agreement to purchase the outstanding shares of the Rütschi Group for a consideration of EUR 68.9 million. The company is planning ahead to work together with potential local, regional, and international suppliers to maximize the opportunities that Newcleo can bring. The company was founded in 2021 by Elisabeth Rizzotti and Stefano Buono, who has been the CEO since 2021.